India is globally recognized for its advanced medical education, high-tech pharmaceutical industry, and significant achievements in producing affordable and quality medicines. International recognition of its expertise in innovative treatment methods, modern clinics, and medical education contributes to strengthening bilateral relations between Uzbekistan and India in the fields of healthcare and pharmaceuticals.
To further strengthen this cooperation, during the visit of the Director of the Agency for the Development of Medicine and Pharmaceuticals, Abdulla Azizov, to the Republic of India, a meeting was held with the management and representatives of ERA University at the India-Uzbekistan Business Forum venue.
During this meeting, issues regarding the development of cooperation in medicine, medical education, and scientific research, improving the quality of personnel training, and implementing joint projects were discussed. During the negotiations, ERA University put forward an initiative to establish a modern clinic in the Karakalpakstan Republic specializing in the early diagnosis, detection, and treatment of rare diseases.
Furthermore, the parties exchanged views on the prospects of launching joint educational programs in medicine and pharmaceuticals, developing academic exchange, conducting scientific research, and enhancing specialist qualifications.
Following the meeting, the parties stated their readiness to expand practical cooperation in medicine and medical education, jointly implement promising projects, and consistently develop bilateral ties.
As part of the visit of the Director of the Agency for the Development of Medicine and Pharmaceuticals, Abdulla Azizov, to the Republic of India, he also participated in a round table organized at the Embassy of Uzbekistan in India under the leadership of the Minister of the Republic of Uzbekistan for Investment, Industry, and Trade, Laziz Kudratov.
The event was held with the assistance of the Confederation of Indian Industry (CII). Dr. Vikramjit Singh Saxena, Chairman of the International Council of CII, as well as leaders and representatives of major Indian companies operating in the pharmaceutical, chemical, banking, and other strategic sectors, took part.
The round table discussed Uzbekistan's investment potential, reforms being carried out in the medical and pharmaceutical sectors, prospects for creating high value-added production, technology transfer, and implementing joint investment projects.
Indian entrepreneurs also presented their proposals and initiatives regarding expanding investment activities in Uzbekistan, establishing joint ventures, and strengthening cooperation between the business communities of the two countries.
The meeting with the Minister of Trade and Industry of the Republic of India, Piyush Goyal, was dedicated to further expanding trade and economic and investment partnership between Uzbekistan and India, increasing mutual trade volumes, developing industrial cooperation, and supporting joint investment projects.
Particular attention at the meeting was paid to deepening cooperation in the pharmaceutical sector. Prospects for the production of medicines and medical devices, technology transfer, scientific research, implementation of innovative developments, and realization of joint projects with high added value were discussed.
In conclusion, the parties emphasized that it is crucial to consistently continue the dialogue on strengthening the strategic partnership between Uzbekistan and India, expanding business ties, and realizing future joint projects.
A local medical equipment manufacturer has received a certificate of conformity to international standards. The certificate was presented to the company "NAM BIOTEST" MCZH by the quality management systems certification body at the Center for Pharmaceutical Product Safety under the Ministry of Health.
Alisher Temirov, Director of the Center for Pharmaceutical Product Safety, emphasized while presenting the certificate to the enterprise head that implementing quality management standards in the production of medical devices is an important factor for the sustainable development of the country's pharmaceutical industry, increasing the competitiveness of local manufacturers, and strengthening export potential.
He also noted that introducing a quality management system based on international requirements is particularly important for ensuring the safety, quality, and reliability of the manufactured products. This certificate confirms that the processes for producing medical devices and diagnostic tools, as well as the organization of quality control at the enterprise, comply with international standards.
This not only strengthens the company's position in the domestic market but also expands opportunities for exporting products to international markets.
"NAM BIOTEST" MCZH, founded in 2019, is one of the leading local enterprises in Uzbekistan specializing in the production of in vitro diagnostic tools and laboratory reagents. The enterprise produces rapid diagnostic tests, ELISA test kits, laboratory reagents, and other diagnostic products using modern technologies.
It is important to note that the ISO 13485 standard establishes international requirements for the quality management system for medical devices. Its implementation contributes to improving production processes, risk management, ensuring compliance with current regulatory requirements and consumer needs, as well as increasing the company's competitiveness and trust in global markets.
The issuance of this certificate is another practical result of the continuous reforms being carried out in the field of medical device production in Uzbekistan, aimed at the widespread adoption of international standards, supporting local manufacturers, and ensuring the healthcare system has high-quality and safe medical goods.
Gulmira Sadullaeva Gaibullo will present her doctoral dissertation in chemical sciences on the topic of 'Synthesis and properties of compounds based on hydroxybenzoic acids, aminopropionic acid fragments, imidazole, and pyrazole.'
The dissertation, dedicated to the topic 'Synthesis and properties of compounds based on hydroxybenzoic acids, aminopropionic acid fragments, imidazole, and pyrazole,' will be defended under specialty 02.00.14 – Organic substances and materials science based on organic substances.
The defense will take place at the meeting of the Scientific Council awarding academic degrees, No. DSc.03/2025.27.12.T.42.01, which will be held on July 28, 2026, at 9:00 AM.
The event will be held at the building of the Tashkent Chemical-Technological Institute administration, on the second floor, in the meeting hall, at the address: Tashkent city, Shaykhontohur district, A. Navoi Street, 32. The institute's contact details include phone (99871) 244-79-20, fax (99871) 244-79-17, and email tkti_info@edu.uz.
The dissertation prepared by Habiba Yaqubova to obtain the scientific degree of Doctor of Philosophy (PhD) in philological sciences will be defended. The dissertation topic is titled 'A Study of the Parallelism between Physiologicalism and Psychologicalism in the Depiction of a Hero of Extraordinary Circumstances in Uzbek Storytelling.'
This scientific work is scheduled to be held at the meeting of the Scientific Council for awarding scientific degrees, PhD.03/2025.27.12.Fil.39.01, under Turan University in Karshi city, on August 5, 2026, at 9:00 AM.
The defense event will take place at Nasaf Street, 1/14 building in Karshi city. Turan University's phone number is (99875) 220-00-25, and its email address is turonuniversity.uz.
